04.12.2012 Views

Final Programme

Final Programme

Final Programme

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

myESR.org<br />

Scientific Sessions<br />

10:30 - 12:00 Room C<br />

Abdominal Viscera (Solid Organs)<br />

SS 201<br />

Liver lesions: CT and MR imaging<br />

Moderators:<br />

P. Pavone; Parma/IT<br />

S. Schmidt; Lausanne/CH<br />

B-011 10:30<br />

Hepatocellular carcinoma (HCC) in cirrhotic liver disease: Value of CT-perfusion in assessment of<br />

tumor-related neoangiogenesis<br />

D. Ippolito, C. Alberzoni, M. Pozzi, L. Antolini, F. Meloni, S. Sironi; Monza/IT<br />

B-012 10:39<br />

Hypervascular enhancing foci on arterial phase images of multiphase dynamic CT in the cirrhotic<br />

liver: Fate and clinical implications<br />

J. Chung, S. Hwang, J.-S. Yu, K. Kim; Seoul/KR<br />

B-013 10:48<br />

Intraindividual comparison of axial and coronal reconstructed images using primary CT raw data at<br />

64-slice CT (MSCT) for the detection of hepatocellular carcinoma (HCC) in cirrhotic patients<br />

D. Marin, C. Catalano, A. Guerrisi, M. Di Martino, G. De Filippis, M. Baski, R. Passariello; Rome/IT<br />

B-014 10:57<br />

Can double-contrast MR imaging (gadolinium-enhanced and ferucarbotran-enhanced MR imaging)<br />

replace triple-phase multidetector CT as the second imaging modality for the diagnosis of small HCC (<<br />

3 cm)?<br />

F. Fusco, A. Bazzocchi, R. Golfi eri; Bologna/IT<br />

B-015 11:06<br />

Quantitative and qualitative evaluation of gadoxetic acid enhanced MR imaging of the liver in patients<br />

with HCC<br />

B.B. Frericks, A. Huppertz, S. Valdeig, T. Nentwig, K.-J. Wolf, T. Albrecht; Berlin/DE<br />

B-016 11:15<br />

Evaluation of vessel maturation and angiogenesis in hepatocellular carcinoma using dynamic<br />

contrast-enhanced MRI at 3.0 Tesla<br />

D. Yu, C. Li, X. Ma, X. Zhang; Jinan/CN<br />

B-017 11:24<br />

Role of SPIO-gadolinium magnetic resonance imaging in screening for hepatocellular carcinoma in<br />

cirrhotic patients<br />

B. Guiu, R. Loffroy, D. Ben Salem, C. Lepage, S. Guiu, S. Aho, J.-L. Jouve, A. Minello, P. Hillon, D. Krause,<br />

J.-P. Cercueil; Dijon/FR<br />

B-018 11:33<br />

Solid hypervascular liver lesions: Accurate identifi cation of true benign lesions on delayed<br />

hepatobiliary phase MR imaging after gadobenate dimeglumine<br />

G. Morana1 , L. Grazioli2 , G. Schneider3 , M. Bondioni2 , N. Faccioli4 , A. Guarise1 , M.A. Kirchin5 ; 1Treviso/IT, 2 3 4 5 Brescia/IT, Homburg a.d. Saar/DE, Verona/IT, Milan/IT<br />

B-019 11:42<br />

MR imaging of focal liver lesions in patients with suspected liver metastasis with Gd-EOB-DTPA<br />

at 3 T: Are there advantages over 1.5 T?<br />

C.J. Zech, K. Herrmann, A. Panteleon, M.F. Reiser, S.O. Schönberg; Munich/DE<br />

B-020 11:51<br />

Radiofrequency ablation of liver tumors: Assessment of treatment outcome with diffusion-weighted<br />

MR imaging<br />

C. Della Pina, R. Lencioni, L. Crocetti, D. Cioni, E. Bozzi, C. Bartolozzi; Pisa/IT<br />

A B C D 259<br />

Friday

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!